Mojdeh Poul - 11 Mar 2026 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role: President & CEO, Director
Signature: /s/ Michael D. Hutchinson; Attorney-in-Fact for Mojdeh Poul
Issuer symbol: IART
Transactions as of: 11 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 12 Mar 2026, 17:07:01 UTC
Previous filing: 07 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Poul Mojdeh	President & CEO, Director	1100 CAMPUS ROAD, PRINCETON	/s/ Michael D. Hutchinson; Attorney-in-Fact for Mojdeh Poul	12 Mar 2026	0001743760

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IART	Restricted Stock Units	Award		+343,393	+336%	$0.000000^*	445,691	11 Mar 2026	Common Stock	343,393	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six month period after the date of her separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

Content

The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six month period after the date of her separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.